Home › Funds › Baader Bank Aktiengesellschaft › BNTX
Baader Bank Aktiengesellschaft position in BNTX
BIONTECH SE · Health Care
Baader Bank Aktiengesellschaft reported holding 119,411 shares of BNTX (BIONTECH SE) in its Q2 2026 13F filing — a position valued at US$11.1M, representing 1.29% of its reported portfolio and ranking #13 among its reported holdings. Baader Bank Aktiengesellschaft has disclosed BNTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Baader Bank Aktiengesellschaft's BNTX position evolved
Baader Bank Aktiengesellschaft first disclosed a stake in BNTX in Q3 2023 at 135,093 shares (US$14.6M). The position peaked in Q3 2024 at 144,281 shares, worth US$17.1M. Across 12 filings, Baader Bank Aktiengesellschaft increased the stake 6 time(s), trimmed it 4 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 119,411 shares valued at US$11.1M — a reduction of -17,014 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 135.09K | $14.62M | New |
| Q4 2023 | 137.26K | $14.39M | Add |
| Q1 2024 | 135.10K | $12.46M | Reduce |
| Q2 2024 | 140.75K | $11.26M | Add |
| Q3 2024 | 144.28K | $17.07M | Add |
| Q4 2024 | 140.40K | $15.99M | Reduce |
| Q1 2025 | 142.82K | $12.94M | Add |
| Q2 2025 | 151.86K | $16.03M | Add |
| Q3 2025 | 152.87K | $14.93M | Add |
| Q4 2025 | 152.34K | $14.38M | Hold |
| Q1 2026 | 136.43K | $12.00M | Reduce |
| Q2 2026 | 119.41K | $11.11M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BNTX and 13F data
BNTX (BIONTECH SE) is a Health Care company. 35 other funds we track also report a position in BNTX — the largest reported positions include FLOSSBACH VON STORCH SE (US$207.1M), Temasek Holdings (Private) Ltd (US$140.1M), Logos Global Management LP (US$94.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BNTX
- FLOSSBACH VON STORCH SE 2.23M sh · $207.14M · Q2 2026
- Temasek Holdings (Private) Ltd 1.51M sh · $140.14M · Q2 2026
- Logos Global Management LP 1.01M sh · $94.45M · Q2 2026
- GSK plc 889.82K sh · $82.80M · Q2 2026
- Davern Capital Partners, LP 754.55K sh · $70.21M · Q2 2026
- Long Focus Capital Management, LLC 624.00K sh · $58.06M · Q2 2026
- TANG CAPITAL MANAGEMENT LLC 470.00K sh · $43.73M · Q2 2026
More on Baader Bank Aktiengesellschaft
FAQ
How long has Baader Bank Aktiengesellschaft held BNTX?
Baader Bank Aktiengesellschaft has disclosed BNTX holdings in 12 of the last 12 reported quarters, going back to Q3 2023.
What is Baader Bank Aktiengesellschaft's current position in BNTX?
As of Q2 2026, Baader Bank Aktiengesellschaft holds 119.41K shares of BNTX (BIONTECH SE), valued at $11.11M, representing 1.29% of its reported portfolio and ranking #13.
Has Baader Bank Aktiengesellschaft been buying or selling BNTX?
In the latest 13F filing (Q2 2026), Baader Bank Aktiengesellschaft reduced its position in BNTX. The position peaked in Q3 2024 at 144.28K shares.
Which other funds hold BNTX?
Other major institutional holders of BNTX include FLOSSBACH VON STORCH SE, Temasek Holdings (Private) Ltd, Logos Global Management LP, among 35 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.